EP Wealth Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$723K Buy
8,393
+1,443
+21% +$130K ﹤0.01% 752
2025
Q4
$607K Buy
+6,950
New +$528K ﹤0.01% 789
2025
Q2
$200K Buy
+3,394
New +$219K ﹤0.01% 1259

Other funds holding GMED

EP Wealth Advisors's GMED Position: Q1 2026 in Review

EP Wealth Advisors increased its Globus Medical (GMED) stake by 21% in Q1 2026, buying an estimated $130K and bringing the position to 8,393 shares worth $723K. The position accounts for ﹤0.01% of the portfolio, ranked #752.

EP Wealth Advisors first reported a position in GMED in Q2 2025 and has held it in 3 quarters since. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • EP Wealth Advisors held 8,393 shares of Globus Medical worth $723K as of Q1 2026.
  • EP Wealth Advisors bought 1,443 Globus Medical shares in Q1 2026, an estimated $130K.
  • Globus Medical made up ﹤0.01% of EP Wealth Advisors's portfolio in Q1 2026, its #752 holding.
  • EP Wealth Advisors first reported a position in Globus Medical in Q2 2025 and has held it in 3 quarters since.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on EP Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.